abrdn Healthcare Investors 

Tekla Healthcare Investors is a closed-end investment fund, which engages in investing in the healthcare industry including biotechnology, medical devices, and pharmaceuticals. Its objective is to provide long-term capital appreciation through investments in companies in the healthcare industry. The company was founded on October 31, 1986 and is headquartered in Boston, MA.

Compass Diversified Holdings

Time in the market trumps timing the market, but the timing of your retirement matters. In retirement, you need a portfolio capable of providing reliable income and mitigating sequence of return risk. We discuss two robust picks geared to provide steady income in retirement.

Worried About A Recession? Income Solutions With Yields Up To 13%

abrdn Healthcare Investors operates as a closed end fund that aims to provide total returns comprised of high current income. HQH offers a high-yielding dividend rate of 12.7% and distributions are paid out on a monthly basis. The fund's focus on biotech holdings makes it vulnerable to interest rate changes but also positions it for potential growth with lower rates.

HQH: High Yielding Exposure To Biotech With Positive Outlook

Flaherty & Crumrine Dynamic Preferred & Income Fund

The prospects of a failed retirement are only heightened by a recession at the start of your retirement. Change the fuel behind your retirement finances with dividends vs. capital withdrawals. Unlock up to 12% yields with these income opportunities.

Retire With Dividends: 2 Picks With Yields Up To 12%

The healthcare sector is traditionally defensive during economic downturns, but not all industries within the healthcare sector are created equal. abrdn Healthcare Investors Fund focuses on the more cyclical biotech space, with over half of its portfolio allocated there. HQH's managed distribution policy was increased significantly since our prior update, which was a factor in the funds discount narrowing, but it continues to trade at an attractive discount.

HQH: Discount Remains Attractive With A Now Higher Distribution Rate

HQH features a deep NAV discount at 11%, it is cheap and offers good opportunity for price appreciation. Biotech sector is showing strength in recent market rally. HQH with high yield at 13% is a good buy for income investors to participate the promising biotech rally. Record financing activities in the sector fuel the business growth and set up for a sustainable market recovery.

HQH: Double-Digit Discount And Dividend Ready For Biotech Rally

Oxford Lane Capital

What is your dream retirement? Make goals to achieve it. Don't make monetary number goals that can't answer the "what then?" question. I meet expenses head-on with highly valuable income.

Make Money While You Sleep, 2 Big Dividends For A Retirement Dream

abrdn Life Sciences Investors 

abrdn World Healthcare Fund 

PHILADELPHIA, PA / ACCESSWIRE / June 26, 2024 / The following abrdn U.S. Closed-End Funds (NYSE:HQH)(NYSE:THQ)(NYSE:THW) announced they each held their Annual Meeting of Shareholders (the "Meetings") on June 25, 2024. At the Meetings, shareholders of the respective Funds voted on the proposals set forth below: abrdn Healthcare Investors ("HQH") As of the record date, April 1, 2024, HQH had outstanding 50,624,847 shares of common stock.

abrdn U.S. Closed-End Funds Announce Results of Annual Meeting of Shareholders

Virtus InfraCap U.S. Preferred Stock ETF

$7.1 trillion is invested in passive ETFs, rocking the market with their inflows and outflows. Few passive ETFs help you achieve specific goals. We look for options to meet our income needs for a lifetime.

2 Magnificent Funds To Generate Passive Income

Healthcare sector's performance lags behind S&P 500 due to high interest rates, regulatory uncertainty, and decreased capital expenditure in the sector.

HQH: Future Rate Cuts Will Help Fund's Performance

PHILADELPHIA, PA / ACCESSWIRE / May 9, 2024 / abrdn Life Sciences Investors (HQL) and abrdn Healthcare Investors (HQH), (collectively, the "Funds") each, a closed-end management investment company, announced today its Board of Trustees (each a "Board" and collectively, the "Boards") have approved an increase in each Fund's respective annualized distribution rate on NAV from 10% to 12%. Notably, HQH and HQL had previously announced distribution increases in February 2024, which increased the annualized distribution rate from 8% to 10%.

abrdn Life Sciences Investors (HQL) and abrdn Healthcare Investors (HQH) Announce an Additional 20% Increase in Distribution Rates Representing a 50% Increase Since January 2024

April showers are over, it is time to focus on our top picks for May. Enjoy the warmer weather, improve your health, and improve your portfolio's exposure to the healthcare sector. We look at two outstanding funds to unlock regular income from this sector.

Buy These 2 Picks If Nothing Else In May

General American Investors

Kayne Anderson MLP Investment

Neuberger Berman Next Generation Connectivity Fund

Royce Value Trust

As contrarians, we search for income stocks that vanilla investors hate. Today there are not many dividend deals left.

5 Cheap Dividend Funds Trading For Pennies On The Dollar

Apollo Tactical Income Fund, Inc.

Atlantica Sustainable Infrastructure

B2Gold

FS Credit Opportunities Corp

Ocugen, Inc.

Perion Network

B. Riley Financial

Rocket Lab USA

SurgePays

AT&T

AT&T 5.35 % Notes 2017-01.11.66 Global

Verizon

Introducing a new recurring series to help you sift through ideas and data on the site: The "Undercovered" Dozen. In this monthly series, we'll cover twelve ideas from the previous month on stocks that receive limited coverage across Seeking Alpha.

The 'Undercovered' Dozen From March 2024

PHILADELPHIA, PA / ACCESSWIRE / March 21, 2024 / abrdn Healthcare Investors (NYSE:HQH), abrdn Life Sciences Investors (NYSE:HQL), abrdn Healthcare Opportunities Fund (NYSE:THQ), and abrdn World Healthcare Fund (NYSE:THW) (collectively, the "Funds") each, a closed-end management investment company, announced today the appointment of Dr. Jason Akus as co-lead portfolio manager to the Funds alongside Dr. Daniel Omstead. Dr. Akus has served on the investment team with Dr. Omstead for over 20 years.

abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Healthcare Opportunities Fund (THQ), and abrdn World Healthcare Fund (THW) Announce Investment Team Update

Blue Owl Capital Corp

I can pay my bills in retirement with cash, and I get that cash from picks like these. Your retirement is going to cost you, so have a way to pay for it. Healthcare and Business Development Companies provide strong income to shareholders.

I Am Loading Up On 2 Bargain Fat Dividends

abrdn Healthcare Investors is a healthcare sector-specific closed-end fund that invests in a portfolio of common stocks in the healthcare industry, heavily weighted in biotechnology. The HQH CEF currently provides a very high yield of 11% plus a high discount of -15% to NAV. HQH has a solid long-term record of nearly 37 years, nearly matching the performance of the S&P 500. However, the recent near- and mid-term performance has been lackluster.

HQH: Healthcare Fund With 11% Income And A High Discount

Automatic Data Processing

Bristol-Myers

BlackRock Science & Technology

Crown Castle International

Calamos Convertible Opportunities And Income Fund

Deere & Company

Enbridge

SPDR Gold Trust

Mastercard

Main Street Capital

MPLX

Microsoft

Realty Income Corp

PIMCO Dynamic Income Fund

PepsiCo

Invesco QQQ

Cohen & Steers Reit And Preferred Income Fund Inc

iShares 20+ Year Treasury Bond ETF

Liberty All Star Equity Fund

Cohen & Steers Infrastructure Fund Inc

Reaves Utility Income Fund

Visa

The Near Perfect Portfolio Strategy provides SWAN-like attributes and aims to meet income and growth goals while minimizing volatility and drawdowns. The strategy consists of three buckets: Dividend Growth Investing, High Income (CEF investing), and Hedging (Rotational bucket). Backtesting results over 17 years show that the strategy has the potential to outperform the S&P 500, with lower drawdowns and volatility.

How To Invest In A SWAN Portfolio: The Near Perfect Portfolio Strategy

PHILADELPHIA, PA / ACCESSWIRE / February 9, 2024 / abrdn Life Sciences Investors (HQL), abrdn Healthcare Investors (HQH), and abrdn Healthcare Opportunities Fund (THQ) (collectively, the "Funds") each, a closed-end management investment company, announced today its Board of Trustees (each a "Board" and collectively, the "Boards") have approved an increase in each Fund's respective distribution rate and announce payment details for the Funds in the chart directly below. Ticker Exchange Fund Distribution Policy Previous Distribution Policy New Declared Distribution Amount HQH NYSE abrdn Healthcare Investors Annualized rate of 8% of rolling NAV Annualized rate of 10% of rolling NAV $ 0.4800 HQL NYSE abrdn Life Sciences Investors Annualized rate of 8% of rolling NAV Annualized rate of 10% of rolling NAV $ 0.3900 THQ NYSE abrdn Healthcare Opportunities Fund $0.1125 per share per month $0.18 per share per month $ 0.1800 HQL and HQH each distribute quarterly, and THQ distributes monthly all or a portion of its net investment income, including current gains, to common shareholders.

abrdn Life Sciences Investors (HQL) and abrdn Healthcare Investors (HQH) Announce a 25% Increase in Distribution Rates and abrdn Healthcare Opportunities Fund (THQ) Announces a 60% Increase in Distribution Rate

The abrdn Healthcare Investors (HQH) fund has a 36-year track record of underperforming peers that does not create confidence for future results. HQH focuses on mid and large-cap biotech and pharmaceutical companies in late-stage clinical trials i.e. FDA approval catalysts. Capital gains distribution requires reinvestment to achieve compounding returns.

HQH: Disappointing Track Record

Dynex Capital

The market is not efficient and it is driven by a few select names. I strongly believe that income is the answer to your expenses. True financial freedom is income overwhelming expenses.

I Am Bottom Fishing: 2 Great Dividends +9%

Ares Capital

Ares Dynamic Credit Allocation Fund

AllianceBernstein Global High Income Fund Inc

BlackRock Taxable Municipal Bond Trust

BlackRock Enhanced Equity Dividend Trust

Central Securities

DNP Select Income Fund Inc

Eaton Vance Enhanced Equity Income Fund II

Energy Transfer LP Unit

Flaherty & Crumrine Preferred Securities Income Fund Inc

Guggenheim Strategic Opportunities Fund

New American High Income Fund

India Fund Inc

Barings Corporate Investors

Annaly Capital

Nuveen Municipal High Income Opportunity Fund

John Hancock Premium Dividend Fund

Cohen And Steers Total Return Realty Fund

2023 year-end review of our 8% Income Portfolio. This high-income portfolio earned over $29,000 in distributions amounting to over 14% yield-on-cost basis and roughly 8.6% on average portfolio value. We will provide updates on trades during the year, dividends collected, and overall performance. As usual, we will compare the performance with a traditional 60:40 stock/bond portfolio.

The 8% Income Portfolio: 2023 Year-End Review

BlackRock Health Sciences Trust II

Saba Capital Income & Opportunities Fund

Blackrock Floating Rate Income Strategies Fund Inc

Nuveen AMT-Free Municipal Value Fund

OFS Credit Company Inc

Invesco S&P 500 Equal Weight ETF

Special Opportunities Fund Inc

SPDR S&P 500 ETF Trust

SPDR S&P Biotech ETF

Health Care Select Sector SPDR Fund

Equity and fixed-income markets had another strong month in December, driven by continuing retreating risk-free Treasury rates. We even saw an improvement in the breadth of the overall market, with broader participation lifting some of the beaten-down sectors for the year. That said, closed-end fund discounts remain historically wide, and that continues to drive opportunity in the CEF wrapper.

5 Closed-End Fund Buys In The Month Of December 2023 (Plus 1 Sell)

Virtus Artificial Intelligence & Technology Opportunities Fund

Global X Artificial Intelligence & Technology ETF

ProShares Ultra Nasdaq Biotechnology

ProShares Ultra Oil & Gas

Eaton Vance Enhanced Equity Income Fund

Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund

Eaton Vance Tax-Managed Global Diversified Equity Income Fund

iShares Nasdaq Biotechnology ETF

Intel

iShares Russell 2000 ETF

NVIDIA

Novo Nordisk

First Trust Cloud Computing ETF

ProShares Ultra S&P 500

Energy Select Sector SPDR Fund

Exxon Mobil

In Part I of my Top Picks For 2024, I explained why we saw such extreme valuation losses in most equity CEFs in 2023 and what that could-mean for 2024. In my opinion, liquidity was the over-riding factor for why so few stocks, think Magnificent 7, received the lion's share of buy-interest while most everything else suffered, including equity CEFs. But just because the Federal Reserve will continue its Quantitative Tapering doesn't mean that other Fed programs won't increase liquidity in other places.

Equity CEFs/ETFs: Top Picks For 2024 - Part II

abrdn Healthcare Investors continues to face pressure as healthcare and biotech sectors remain out of favor. HQH remains an attractive buy if one believes that the healthcare and biotech space can rebound in time and also offers a significant discount. HQH offers an attractive distribution while waiting for the sector to turn around to more favorable times.

HQH: Remains Beaten Down But Also Remains An Interesting Prospect

How's the colder weather treating you? Fighting a cold? I get paid by the healthcare sector, and every year, I'm reminded why exposure to this sector is a must. Let the doctors and big pharma pay for your retirement.

HQH: I Am Getting A 9.5% Yield On My Last Buy

News for abrdn Healthcare Investors ETF (HQH)